Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRIUMPH: Rucaparib in mHSPC
NCT03413995Phase 2Completed
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center
- Start
- Sep 2018
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rucaparib in prostate cancer (PCa), sponsored by Sidney Kimmel Comprehensive Cancer Center. Started Sep 2018; status: completed.
02
Drugs
rucaparib
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT03413995.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03413995.